Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Raj Shah

Concepts (348)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiopancreatography, Endoscopic Retrograde
45
2025
212
10.130
 Why?
Endoscopy, Digestive System
22
2024
135
6.380
 Why?
Pancreatic Ducts
22
2024
79
6.250
 Why?
Pancreatic Diseases
14
2024
67
4.860
 Why?
Pancreatitis, Chronic
12
2024
61
4.560
 Why?
Calculi
8
2022
16
3.970
 Why?
Bile Duct Neoplasms
13
2021
114
3.480
 Why?
Endosonography
25
2024
153
3.450
 Why?
Lithotripsy
11
2024
46
3.280
 Why?
Stents
20
2024
529
3.140
 Why?
Cholangitis, Sclerosing
8
2022
56
2.870
 Why?
Pancreatic Neoplasms
20
2024
882
2.600
 Why?
Cholangiocarcinoma
7
2021
94
2.500
 Why?
Drainage
10
2024
174
2.050
 Why?
Bile Ducts, Intrahepatic
5
2021
58
1.950
 Why?
Bile Ducts
9
2019
66
1.840
 Why?
Biliary Tract Surgical Procedures
4
2021
27
1.790
 Why?
Endoscopy, Gastrointestinal
12
2023
232
1.750
 Why?
Constriction, Pathologic
15
2022
238
1.660
 Why?
Pancreatic Pseudocyst
5
2024
17
1.300
 Why?
Gallstones
4
2018
33
1.290
 Why?
Microscopy, Confocal
8
2021
324
1.240
 Why?
Pancreas
6
2021
326
1.220
 Why?
Biliary Tract Diseases
4
2016
33
1.210
 Why?
Cholestasis
7
2021
207
1.110
 Why?
Endoscopes
3
2017
17
1.080
 Why?
Aged
51
2025
24574
1.000
 Why?
Carcinoma, Pancreatic Ductal
5
2016
277
0.990
 Why?
Middle Aged
59
2025
34434
0.990
 Why?
Treatment Outcome
30
2025
11120
0.940
 Why?
Adenocarcinoma
7
2023
892
0.880
 Why?
Retrospective Studies
30
2025
16273
0.870
 Why?
Pancreatitis
5
2024
136
0.870
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
7
2019
56
0.860
 Why?
Endoscopy
4
2015
322
0.850
 Why?
Endoscopes, Gastrointestinal
8
2013
13
0.850
 Why?
Common Bile Duct Neoplasms
1
2023
23
0.820
 Why?
Duodenal Neoplasms
1
2023
24
0.820
 Why?
Ampulla of Vater
1
2023
34
0.820
 Why?
Humans
108
2025
141187
0.810
 Why?
Choledochal Cyst
2
2020
17
0.800
 Why?
Laparoscopy
4
2021
463
0.790
 Why?
Hepatic Encephalopathy
1
2022
25
0.760
 Why?
Adenocarcinoma, Mucinous
2
2016
76
0.760
 Why?
Gastrointestinal Tract
1
2025
204
0.750
 Why?
Male
64
2025
69783
0.750
 Why?
Pancreatectomy
3
2021
262
0.750
 Why?
Catheterization
8
2024
182
0.750
 Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2022
38
0.740
 Why?
Female
66
2025
75515
0.730
 Why?
Cholangitis
1
2022
19
0.730
 Why?
Hypertension, Portal
1
2022
64
0.730
 Why?
Adenoma
2
2023
220
0.730
 Why?
End Stage Liver Disease
1
2022
76
0.700
 Why?
Calcinosis
2
2019
238
0.650
 Why?
Cytodiagnosis
1
2020
32
0.650
 Why?
Intestine, Small
2
2019
156
0.620
 Why?
In Situ Hybridization, Fluorescence
1
2020
310
0.600
 Why?
Adult
36
2025
39177
0.570
 Why?
Lithotripsy, Laser
2
2015
4
0.570
 Why?
Aged, 80 and over
18
2025
7856
0.560
 Why?
Quality of Life
4
2024
2999
0.560
 Why?
Artificial Intelligence
1
2022
334
0.550
 Why?
Aneurysm, False
1
2018
45
0.550
 Why?
Prospective Studies
23
2024
7739
0.530
 Why?
Liver Neoplasms
1
2023
740
0.530
 Why?
Foreign Bodies
1
2018
107
0.530
 Why?
Disposable Equipment
1
2017
21
0.530
 Why?
Laser Therapy
1
2018
127
0.510
 Why?
Polyethylene
1
2016
17
0.480
 Why?
Biopsy
6
2018
1081
0.480
 Why?
Gallbladder Diseases
1
2015
12
0.470
 Why?
Gastroenterology
4
2019
182
0.470
 Why?
Gastrointestinal Diseases
5
2022
207
0.450
 Why?
Pancreatic Juice
1
2014
2
0.450
 Why?
Learning Curve
5
2019
70
0.440
 Why?
Biomarkers, Tumor
2
2014
1251
0.430
 Why?
Sphincterotomy, Endoscopic
4
2019
29
0.430
 Why?
CA-19-9 Antigen
1
2014
29
0.430
 Why?
Metals
4
2023
140
0.420
 Why?
Sensitivity and Specificity
9
2021
1973
0.420
 Why?
Postoperative Complications
3
2022
2797
0.410
 Why?
Cholestasis, Intrahepatic
1
2013
29
0.390
 Why?
Hemorrhage
1
2018
760
0.390
 Why?
Ultrasonography, Interventional
3
2022
155
0.380
 Why?
Pancreatitis, Acute Necrotizing
2
2023
14
0.370
 Why?
Follow-Up Studies
12
2021
5200
0.370
 Why?
Predictive Value of Tests
7
2017
2070
0.360
 Why?
Anastomosis, Roux-en-Y
2
2022
26
0.350
 Why?
Liver Diseases
1
2014
301
0.350
 Why?
Young Adult
9
2025
13673
0.330
 Why?
Biliary Tract Neoplasms
3
2016
31
0.330
 Why?
Clinical Competence
5
2019
1202
0.330
 Why?
Foreign-Body Migration
2
2006
32
0.290
 Why?
Natural Orifice Endoscopic Surgery
3
2018
35
0.280
 Why?
Pancreatic Cyst
3
2018
48
0.280
 Why?
Needles
3
2019
63
0.280
 Why?
B7-1 Antigen
1
2008
58
0.280
 Why?
Gastrointestinal Hemorrhage
2
2008
134
0.280
 Why?
Video Recording
4
2016
190
0.270
 Why?
Fluorouracil
4
2020
206
0.260
 Why?
Bile Ducts, Extrahepatic
2
2020
18
0.260
 Why?
Gallbladder
2
2022
15
0.260
 Why?
Dilatation
2
2018
69
0.260
 Why?
Abdominal Pain
4
2023
145
0.250
 Why?
Adolescent
11
2025
22007
0.240
 Why?
Cholelithiasis
3
2015
37
0.240
 Why?
Autonomic Nerve Block
1
2024
10
0.230
 Why?
Celiac Plexus
1
2024
6
0.230
 Why?
Hemostatic Techniques
1
2005
50
0.220
 Why?
Indomethacin
1
2024
87
0.220
 Why?
Catheters
2
2015
74
0.220
 Why?
Peritoneal Neoplasms
1
2005
98
0.220
 Why?
Ambulatory Care Facilities
1
2006
248
0.210
 Why?
Guanidines
1
2023
41
0.210
 Why?
Tumor Suppressor Protein p53
1
2008
528
0.210
 Why?
Equipment Design
9
2013
525
0.210
 Why?
Esters
1
2023
77
0.200
 Why?
Cholecystitis, Acute
1
2022
23
0.190
 Why?
Self Expandable Metallic Stents
1
2022
16
0.190
 Why?
Prosthesis Implantation
2
2019
157
0.190
 Why?
Pain
3
2022
781
0.190
 Why?
Choledochostomy
1
2022
10
0.190
 Why?
Pain Measurement
1
2024
554
0.190
 Why?
Plastics
2
2022
50
0.180
 Why?
Analgesics, Opioid
2
2024
1116
0.180
 Why?
Multiple Myeloma
1
2005
282
0.180
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
348
0.180
 Why?
Multivariate Analysis
3
2021
1490
0.180
 Why?
Antimetabolites, Antineoplastic
2
2020
93
0.170
 Why?
Multicenter Studies as Topic
1
2022
338
0.170
 Why?
United States
9
2017
15220
0.170
 Why?
Tegafur
1
2020
6
0.170
 Why?
Oxonic Acid
1
2020
8
0.160
 Why?
Lasers
1
2021
130
0.160
 Why?
Logistic Models
3
2021
2086
0.160
 Why?
Dissection
2
2018
55
0.160
 Why?
Randomized Controlled Trials as Topic
4
2022
1556
0.160
 Why?
Living Donors
1
2022
268
0.160
 Why?
Fiducial Markers
1
2019
9
0.150
 Why?
Hydrogen Peroxide
1
2021
339
0.150
 Why?
Urinary Calculi
1
2019
10
0.150
 Why?
ROC Curve
2
2018
586
0.150
 Why?
Carcinoembryonic Antigen
2
2018
38
0.150
 Why?
Radiotherapy, Image-Guided
1
2019
37
0.150
 Why?
Carcinoma, Squamous Cell
1
2004
642
0.150
 Why?
Severity of Illness Index
2
2022
2892
0.150
 Why?
Reproducibility of Results
4
2019
3348
0.150
 Why?
Risk Factors
6
2024
10438
0.140
 Why?
Anastomosis, Surgical
1
2019
159
0.140
 Why?
Lasers, Solid-State
1
2018
23
0.140
 Why?
Journal Impact Factor
1
2018
29
0.140
 Why?
Cystadenoma, Serous
1
2018
18
0.140
 Why?
Cholecystectomy, Laparoscopic
1
2018
52
0.140
 Why?
Gastric Outlet Obstruction
1
2017
12
0.140
 Why?
Fiber Optic Technology
2
2015
24
0.140
 Why?
Hospitals, University
1
2018
175
0.140
 Why?
Diagnosis, Differential
3
2015
1498
0.130
 Why?
Parkinsonian Disorders
1
2017
43
0.130
 Why?
Neoplasm Recurrence, Local
1
2023
1073
0.130
 Why?
Urinary Incontinence
1
2017
65
0.130
 Why?
Gastrointestinal Neoplasms
2
2008
76
0.130
 Why?
Narrow Band Imaging
1
2016
14
0.130
 Why?
Education, Medical, Graduate
2
2019
522
0.130
 Why?
Feasibility Studies
4
2018
1018
0.130
 Why?
Reoperation
1
2019
588
0.120
 Why?
Neuroendocrine Tumors
1
2018
109
0.120
 Why?
Time Factors
3
2019
6956
0.120
 Why?
Regression Analysis
1
2018
1020
0.120
 Why?
Gastric Bypass
1
2017
119
0.120
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
26
0.120
 Why?
Neoplasm Staging
6
2013
1398
0.120
 Why?
Cystadenoma, Mucinous
1
2015
10
0.120
 Why?
Cystadenocarcinoma, Mucinous
1
2015
11
0.120
 Why?
Periodicals as Topic
1
2018
217
0.120
 Why?
Pathology, Clinical
1
2015
29
0.120
 Why?
Single-Blind Method
1
2016
288
0.110
 Why?
Fellowships and Scholarships
1
2019
319
0.110
 Why?
Radio Waves
1
2015
28
0.110
 Why?
Pancreaticoduodenectomy
1
2016
129
0.110
 Why?
Incidence
2
2018
2794
0.110
 Why?
Fluoroscopy
3
2019
169
0.100
 Why?
Europe
1
2014
410
0.100
 Why?
Tertiary Care Centers
1
2014
178
0.100
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1787
0.100
 Why?
Length of Stay
1
2019
1254
0.100
 Why?
Double-Balloon Enteroscopy
1
2013
1
0.100
 Why?
Disinfection
2
2018
128
0.100
 Why?
Databases, Factual
1
2018
1444
0.090
 Why?
Cyst Fluid
2
2018
21
0.090
 Why?
Colonoscopy
2
2018
250
0.090
 Why?
Referral and Consultation
2
2016
798
0.090
 Why?
Academic Medical Centers
2
2017
528
0.090
 Why?
Catheter Ablation
1
2015
313
0.090
 Why?
Technology Assessment, Biomedical
2
2008
40
0.090
 Why?
Chemoradiotherapy
1
2013
232
0.090
 Why?
Carcinoma
1
2013
230
0.090
 Why?
Deoxycytidine
2
2013
192
0.090
 Why?
Esophageal Neoplasms
2
2005
333
0.090
 Why?
Cohort Studies
2
2014
5799
0.090
 Why?
Biopsy, Fine-Needle
2
2008
70
0.090
 Why?
Parkinson Disease
1
2017
569
0.090
 Why?
Antibiotic Prophylaxis
1
2012
122
0.090
 Why?
Child
4
2018
22308
0.080
 Why?
Radiography
1
2013
844
0.080
 Why?
Practice Guidelines as Topic
1
2018
1597
0.080
 Why?
Minimally Invasive Surgical Procedures
2
2008
179
0.080
 Why?
Colorado
2
2018
4610
0.080
 Why?
Abdominal Abscess
1
2009
25
0.080
 Why?
Colonography, Computed Tomographic
1
2009
8
0.080
 Why?
Palliative Care
2
2009
817
0.080
 Why?
Risk Assessment
4
2016
3490
0.070
 Why?
Capsule Endoscopy
1
2008
18
0.070
 Why?
Prognosis
3
2016
4073
0.070
 Why?
Decompression, Surgical
1
2009
113
0.070
 Why?
Intestinal Perforation
1
2008
45
0.070
 Why?
Duodenum
1
2008
74
0.070
 Why?
Gastric Mucosa
1
2008
53
0.070
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2008
6
0.070
 Why?
Tissue Fixation
1
2008
37
0.070
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2008
34
0.070
 Why?
Equipment Safety
4
2008
37
0.070
 Why?
Balloon Occlusion
1
2008
36
0.070
 Why?
Wounds, Penetrating
1
2008
71
0.070
 Why?
Immunoenzyme Techniques
1
2008
209
0.070
 Why?
Medical Records Systems, Computerized
1
2008
96
0.070
 Why?
Coloring Agents
1
2007
96
0.070
 Why?
Radiotherapy, Intensity-Modulated
1
2008
137
0.070
 Why?
Image Enhancement
1
2008
191
0.060
 Why?
Rectal Neoplasms
1
2008
152
0.060
 Why?
Liver
2
2005
1819
0.060
 Why?
Duodenoscopy
1
2006
7
0.060
 Why?
Laser Coagulation
1
2006
71
0.060
 Why?
Intestinal Mucosa
2
2008
631
0.060
 Why?
Prosthesis Design
2
2009
335
0.060
 Why?
Tomography, X-Ray Computed
2
2014
2746
0.060
 Why?
Conscious Sedation
1
2006
94
0.060
 Why?
Ascites
1
2005
47
0.060
 Why?
Anesthesia, General
1
2006
117
0.060
 Why?
Thoracic Neoplasms
1
2005
39
0.060
 Why?
Acute Disease
1
2008
1008
0.060
 Why?
Administration, Rectal
1
2024
13
0.060
 Why?
Equipment Failure
1
2005
111
0.060
 Why?
Growth Substances
1
2004
148
0.050
 Why?
Pain Management
1
2008
396
0.050
 Why?
Radiotherapy, Adjuvant
3
2013
219
0.050
 Why?
Immunoglobulin A
1
2005
214
0.050
 Why?
Chemotherapy, Adjuvant
3
2013
378
0.050
 Why?
Liver Cirrhosis
1
2006
282
0.050
 Why?
Infant
1
2018
9818
0.050
 Why?
International Cooperation
2
2017
203
0.050
 Why?
Child, Preschool
1
2018
11457
0.050
 Why?
Neoplasm Metastasis
1
2005
674
0.050
 Why?
Diagnostic Tests, Routine
1
2003
110
0.050
 Why?
Pilot Projects
1
2008
1820
0.050
 Why?
Necrosis
1
2023
249
0.050
 Why?
Odds Ratio
2
2016
1052
0.040
 Why?
Combined Modality Therapy
3
2013
1243
0.040
 Why?
Anti-Infective Agents, Local
1
2021
40
0.040
 Why?
Polycystic Kidney, Autosomal Dominant
1
2004
266
0.040
 Why?
Drug Combinations
1
2020
358
0.040
 Why?
Disease-Free Survival
2
2013
715
0.040
 Why?
Double-Blind Method
1
2023
1983
0.040
 Why?
Kaplan-Meier Estimate
2
2013
908
0.040
 Why?
Myotomy
1
2018
15
0.040
 Why?
Endoscopic Mucosal Resection
1
2018
27
0.030
 Why?
Equipment Contamination
1
2018
71
0.030
 Why?
Republic of Korea
1
2017
41
0.030
 Why?
Administration, Oral
1
2020
803
0.030
 Why?
Surgical Instruments
1
2018
50
0.030
 Why?
Bile
2
2009
25
0.030
 Why?
Autopsy
1
2017
98
0.030
 Why?
Surgery, Computer-Assisted
1
2018
78
0.030
 Why?
Prosthesis Failure
2
2009
125
0.030
 Why?
Colonic Polyps
1
2018
82
0.030
 Why?
United Kingdom
1
2017
322
0.030
 Why?
Cytokines
1
2004
2098
0.030
 Why?
Hospitalization
1
2006
2255
0.030
 Why?
Videotape Recording
1
2016
39
0.030
 Why?
Gastroenterologists
1
2016
16
0.030
 Why?
Barrett Esophagus
1
2018
158
0.030
 Why?
Geriatric Assessment
1
2017
221
0.030
 Why?
Radiologists
1
2016
52
0.030
 Why?
Quality Indicators, Health Care
1
2018
308
0.030
 Why?
Watchful Waiting
1
2016
84
0.030
 Why?
Surveys and Questionnaires
1
2008
5929
0.030
 Why?
Phantoms, Imaging
1
2016
150
0.030
 Why?
Disease Management
1
2018
633
0.030
 Why?
Societies, Medical
2
2008
855
0.030
 Why?
Inflammatory Bowel Diseases
1
2018
358
0.030
 Why?
Organoplatinum Compounds
1
2013
49
0.030
 Why?
Leucovorin
1
2013
86
0.020
 Why?
Injections, Intralesional
1
2013
35
0.020
 Why?
Erlotinib Hydrochloride
1
2013
69
0.020
 Why?
Program Evaluation
1
2017
928
0.020
 Why?
Camptothecin
1
2013
122
0.020
 Why?
Comorbidity
1
2017
1662
0.020
 Why?
Treatment Failure
1
2013
354
0.020
 Why?
False Negative Reactions
1
2011
61
0.020
 Why?
Quinazolines
1
2013
250
0.020
 Why?
False Positive Reactions
1
2011
125
0.020
 Why?
Drug Administration Schedule
1
2013
771
0.020
 Why?
Neoadjuvant Therapy
1
2013
419
0.020
 Why?
Colorectal Neoplasms
1
2018
802
0.020
 Why?
Longitudinal Studies
1
2017
2902
0.020
 Why?
Stainless Steel
1
2009
20
0.020
 Why?
Hematoma
1
2009
54
0.020
 Why?
Alloys
1
2009
37
0.020
 Why?
Terminally Ill
1
2009
37
0.020
 Why?
Observer Variation
1
2010
355
0.020
 Why?
Medical Laboratory Science
1
2008
9
0.020
 Why?
Rupture
1
2008
88
0.020
 Why?
Miniaturization
1
2008
22
0.020
 Why?
Ligation
1
2008
93
0.020
 Why?
Capecitabine
1
2008
42
0.020
 Why?
Probability
1
2009
309
0.020
 Why?
Premedication
1
2008
41
0.020
 Why?
Total Quality Management
1
2008
61
0.020
 Why?
Esophageal and Gastric Varices
1
2008
35
0.020
 Why?
Evaluation Studies as Topic
1
2008
175
0.020
 Why?
Forms and Records Control
1
2008
21
0.020
 Why?
Radiotherapy Dosage
1
2008
281
0.020
 Why?
Morbidity
1
2008
322
0.020
 Why?
Remission Induction
1
2008
309
0.020
 Why?
Diarrhea
1
2008
183
0.020
 Why?
Safety Management
1
2008
126
0.020
 Why?
Biopsy, Needle
1
2007
187
0.020
 Why?
Injections
1
2007
191
0.020
 Why?
Costs and Cost Analysis
1
2007
222
0.020
 Why?
DNA
1
2013
1444
0.020
 Why?
Survival Analysis
1
2009
1319
0.010
 Why?
Information Dissemination
1
2008
224
0.010
 Why?
Safety
1
2007
356
0.010
 Why?
Patient Selection
1
2009
688
0.010
 Why?
Prostheses and Implants
1
2006
144
0.010
 Why?
Receptors, Interleukin-8B
1
2004
26
0.010
 Why?
Obesity
1
2018
3004
0.010
 Why?
Esophagectomy
1
2005
137
0.010
 Why?
Survival Rate
1
2008
1970
0.010
 Why?
Recurrence
1
2007
1110
0.010
 Why?
Swine
1
2006
806
0.010
 Why?
Positron-Emission Tomography
1
2005
310
0.010
 Why?
Ischemia
1
2004
415
0.010
 Why?
Epithelial Cells
1
2004
1110
0.010
 Why?
Cells, Cultured
1
2004
4208
0.010
 Why?
Biomarkers
1
2008
4174
0.010
 Why?
Disease Models, Animal
1
2006
4404
0.010
 Why?
Animals
1
2006
37657
0.000
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (348) concept(s)
_
Co-Authors Expand Description
See all (22) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)